393 related articles for article (PubMed ID: 15910995)
1. IgG from acutely infected cats blocks mucosal feline immunodeficiency virus infection.
Burkhard MJ; Hoover EA
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):87-95. PubMed ID: 15910995
[TBL] [Abstract][Full Text] [Related]
2. Toward a detailed characterization of feline immunodeficiency virus-specific T cell immune responses and mediated immune disorders.
Paillot R; Richard S; Bloas F; Piras F; Poulet H; Brunet S; Andreoni C; Juillard V
Vet Immunol Immunopathol; 2005 Jun; 106(1-2):1-14. PubMed ID: 15910988
[TBL] [Abstract][Full Text] [Related]
3. Mucosal administration of low-dose cell-associated feline immunodeficiency virus promotes viral latency.
Assogba BD; Leavell S; Porter K; Burkhard MJ
J Infect Dis; 2007 Apr; 195(8):1184-8. PubMed ID: 17357056
[TBL] [Abstract][Full Text] [Related]
4. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
[TBL] [Abstract][Full Text] [Related]
5. Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus.
Burkhard MJ; Obert LA; O'Neil LL; Diehl LJ; Hoover EA
AIDS Res Hum Retroviruses; 1997 Mar; 13(4):347-55. PubMed ID: 9071435
[TBL] [Abstract][Full Text] [Related]
6. Mutations in feline immunodeficiency (FIV) virus envelope gene V3-V5 regions in FIV-infected cats.
Motokawa K; Hohdatsu T; Imori A; Arai S; Koyama H
Vet Microbiol; 2005 Mar; 106(1-2):33-40. PubMed ID: 15737471
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
[TBL] [Abstract][Full Text] [Related]
8. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.
Pu R; Okada S; Little ER; Xu B; Stoffs WV; Yamamoto JK
AIDS; 1995 Mar; 9(3):235-42. PubMed ID: 7755911
[TBL] [Abstract][Full Text] [Related]
9. Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.
Richards JR
Biologicals; 2005 Dec; 33(4):215-7. PubMed ID: 16257536
[TBL] [Abstract][Full Text] [Related]
10. Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection.
Folkl A; Wen X; Kuczynski E; Clark ME; Bienzle D
Vet Immunol Immunopathol; 2010 Mar; 134(1-2):107-14. PubMed ID: 19931185
[TBL] [Abstract][Full Text] [Related]
11. CD8+ T cells from feline immunodeficiency virus (FIV) infected cats suppress exogenous FIV replication of their peripheral blood mononuclear cells in vitro.
Hohdatsu T; Sasagawa T; Yamazaki A; Motokawa K; Kusuhara H; Kaneshima T; Koyama H
Arch Virol; 2002 Aug; 147(8):1517-29. PubMed ID: 12181672
[TBL] [Abstract][Full Text] [Related]
12. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
Huang C; Conlee D; Gill M; Chu HJ
J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
[TBL] [Abstract][Full Text] [Related]
13. Shedding of feline immunodeficiency virus in semen of domestic cats during acute infection.
Jordan HL; Liang Y; Hudson LC; Tompkins WA
Am J Vet Res; 1999 Feb; 60(2):211-5. PubMed ID: 10048554
[TBL] [Abstract][Full Text] [Related]
14. An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.
Siebelink CH; Windrich RW; Chu I; Groen J; Weijer K; UytdeHaag FG; Osterhaus AD
Dev Biol Stand; 1990; 72():189-96. PubMed ID: 2178115
[TBL] [Abstract][Full Text] [Related]
15. Productive infection of the bone marrow cells in feline immunodeficiency virus infected cats.
Sandy JR; Robinson WF; Bredhauer B; Kyaw-Tanner M; Howlett CR
Arch Virol; 2002 May; 147(5):1053-9. PubMed ID: 12021873
[TBL] [Abstract][Full Text] [Related]
16. Lessons from the cat: development of vaccines against lentiviruses.
Dunham SP
Vet Immunol Immunopathol; 2006 Jul; 112(1-2):67-77. PubMed ID: 16678276
[TBL] [Abstract][Full Text] [Related]
17. Serological differentiation of FIV-infected cats from dual-subtype feline immunodeficiency virus vaccine (Fel-O-Vax FIV) inoculated cats.
Kusuhara H; Hohdatsu T; Seta T; Nemoto K; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
Vet Microbiol; 2007 Mar; 120(3-4):217-25. PubMed ID: 17141431
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the plasma globulin level, CD21(-) B-cell counts and FOXP3 mRNA expression level in CD4(+) T-cells for different clinical stages of feline immunodeficiency virus infected cats.
Takano T; Hosoya S; Shibao A; Nagasaki B; Yoshioka H; Satoh R; Hohdatsu T
Res Vet Sci; 2012 Feb; 92(1):157-61. PubMed ID: 21074227
[TBL] [Abstract][Full Text] [Related]
19. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.
Yamamoto JK; Sparger E; Ho EW; Andersen PR; O'Connor TP; Mandell CP; Lowenstine L; Munn R; Pedersen NC
Am J Vet Res; 1988 Aug; 49(8):1246-58. PubMed ID: 2459996
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
